Pulmonary tumor thrombotic microangiopathy caused by a parotid tumor: Early antemortem diagnosis and long-term survival

12Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

Abstract

Pulmonary tumor thrombotic microangiopathy (PTTM) is a high-mortality disease that is difficult to diagnose clinically. Our patient was an 80-year-old woman who came to us due to symptoms of increasing dyspnea. A clinical evaluation showed that she had hypoxemia and pulmonary arterial hypertension without any abnormalities in the major pulmonary arteries, bronchi, or alveoli. A lung perfusion scan showed multiple wedge-shaped perfusion defects. Further examination revealed adenocarcinoma in her right parotid gland with metastasis to the submandibular lymph nodes. We diagnosed her to have PTTM caused by a parotid tumor. The patient survived for 11 months with chemotherapy. An early antemortem diagnosis by minimally invasive examinations will help PTTM patients to survive longer.

Cite

CITATION STYLE

APA

Toyonaga, H., Tsuchiya, M., Sakaguchi, C., Ajimizu, H., Nakanishi, Y., Nishiyama, S., … Yasui, H. (2017). Pulmonary tumor thrombotic microangiopathy caused by a parotid tumor: Early antemortem diagnosis and long-term survival. Internal Medicine, 56(1), 67–71. https://doi.org/10.2169/internalmedicine.56.7439

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free